Question · asked by 1 review
RISPERIDONE DEPOT vs GENERAL ORAL ANTIPSYCHOTICS: Adverse events: General: Severe adverse event ‐ any dose risperidone depot ‐ short term
- Population
- patients with schizophrenia
- Intervention
- RISPERIDONE DEPOT
- Comparison
- GENERAL ORAL ANTIPSYCHOTICS
- Outcome
- Adverse events: General: Severe adverse event ‐ any dose risperidone depot ‐ short term
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
RISPERIDONE DEPOT vs GENERAL ORAL ANTIPSYCHOTICS Adverse events: General: Severe adverse event ‐ any dose risperidone depot ‐ short term · patients with schizophrenia Risperidone (depot) for schizophrenia (2016) · Cochrane Headline outcomes only | no estimate extracted | 0 studies · 0 participants | GRADE not reported |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Risperidone (depot) for schizophrenia 2016 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- RISPERIDONE DEPOT vs RISPERIDONE · patients with schizophrenia · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.